Bill Text: HI SB2228 | 2012 | Regular Session | Amended

---

Bill Title: Pseudoephedrine; Tracking

Spectrum: Partisan Bill (Democrat 2-0)

Status: (Passed) 2012-06-15 - (S) Act 119, 6/15/2012 (Gov. Msg. No. 1221). [SB2228 Detail]

Download: Hawaii-2012-SB2228-Amended.html

---

 

 

STAND. COM. REP. NO.  1558-12

 

Honolulu, Hawaii

                , 2012

 

RE:   S.B. No. 2228

      S.D. 2

      H.D. 2

 

 

 

 

Honorable Calvin K.Y. Say

Speaker, House of Representatives

Twenty-Sixth State Legislature

Regular Session of 2012

State of Hawaii

 

Sir:

 

     Your Committee on Judiciary, to which was referred S.B. No. 2228, S.D. 2, H.D. 1, entitled:

 

"A BILL FOR AN ACT RELATING TO PSEUDOEPHEDRINE,"

 

begs leave to report as follows:

 

     The purpose of this measure is to monitor the sale of

products containing pseudoephedrine by, among other things:

 

     (1)  Requiring pharmacies or retailers to maintain a written

or electronic log of specified information for each sale

of nonprescription products containing pseudoephedrine;

 

     (2)  Requiring pharmacies or retailers after January 1, 2013,

to electronically submit the information required for

the written or electronic log to the National Precursor

Log Exchange prior to completing a sale, and prohibiting

pharmacies or retailers from completing the

transaction if a stop alert is generated upon the

electronic submission; and

 

     (3)  Requiring the Department of Public Safety Narcotics

Enforcement Division to implement an electronic tracking

system no later than January 1, 2015, in conjunction

with the State’s existing narcotics tracking system to

interface with the National Precursor Log Exchange.

 

     The Hawaii Food Industry Association and Legislative

Information Services of Hawaii testified in support of this

measure. The Department of Public Safety testified in support of

the intent of this measure.

 

     Your Committee has amended this measure by:

 

     (1)  Making references to the entities and individuals covered by this measure consistent, including replacing the term "seller" with the term "pharmacy or retailer"; and

 

     (2)  Making technical, nonsubstantive amendments for clarity, consistency, and style.

 

     As affirmed by the record of votes of the members of your Committee on Judiciary that is attached to this report, your Committee is in accord with the intent and purpose of S.B. No. 2228, S.D. 2, H.D. 1, as amended herein, and recommends that it pass Third Reading in the form attached hereto as S.B. No. 2228, S.D. 2, H.D. 2.

 

Respectfully submitted on behalf of the members of the Committee on Judiciary,

 

 

		____________________________ GILBERT KEITH-AGARAN, Chair